Molecular Mechanisms and Bioavailability of Polyphenols in Prostate Cancer

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2019 Mar 3

PMID 30823649

Citations 27

Authors

Teodora Costea

Peter Nagy

Constanta Ganea

Janos Szollosi

Maria-Magdalena Mocanu

Affiliations

Soon will be listed here.

Abstract

Prostate cancer is the one of the most frequently diagnosed cancers among men over the age of 50. Several lines of evidence support the observation that polyphenols have preventive and therapeutic effects in prostate cancer. Moreover, prostate cancer is ideal for chemoprevention due to its long latency. We propose here an equilibrated lifestyle with a diet rich in polyphenols as prophylactic attempts to slow down the progression of localized prostate cancer or prevent the occurrence of the disease. In this review, we will first summarize the molecular mechanisms of polyphenols in prostate cancer with a focus on the antioxidant and pro-oxidant effects, androgen receptors (AR), key molecules involved in AR signaling and their transactivation pathways, cell cycle, apoptosis, angiogenesis, metastasis, genetic aspects, and epigenetic mechanisms. The relevance of the molecular mechanisms is discussed in light of current bioavailability data regarding the activity of polyphenols in prostate cancer. We also highlight strategies for improving the bioavailability of polyphenols. We hope that this review will lead to further research regarding the bioavailability and the role of polyphenols in prostate cancer prevention and treatment.

Citing Articles

Polyphenols: From Classification to Therapeutic Potential and Bioavailability.

Ciupei D, Colisar A, Leopold L, Stanila A, Diaconeasa Z Foods. 2025; 13(24.

PMID: 39767073 PMC: 11675957. DOI: 10.3390/foods13244131.

Synergistic Strategies for Castration-Resistant Prostate Cancer: Targeting AR-V7, Exploring Natural Compounds, and Optimizing FDA-Approved Therapies.

Rahman M, Akter K, Ahmed K, Maharub Hossain Fahim M, Aktary N, Park M Cancers (Basel). 2024; 16(16).

PMID: 39199550 PMC: 11352813. DOI: 10.3390/cancers16162777.

Association between polyphenol subclasses and prostate cancer: a systematic review and meta-analysis of observational studies.

Huang Y, Wang W, Jin J Front Nutr. 2024; 11:1428911.

PMID: 39144286 PMC: 11322767. DOI: 10.3389/fnut.2024.1428911.

Dietary Plant Metabolites Induced Epigenetic Modification as a Novel Strategy for the Management of Prostate Cancer.

Singh V, Shirbhate E, Kore R, Mishra A, Johariya V, Veerasamy R Mini Rev Med Chem. 2024; 24(15):1409-1426.

PMID: 38385496 DOI: 10.2174/0113895575283895240207065454.

Recent updates on nano-phyto-formulations based therapeutic intervention for cancer treatment.

Wahi A, Bishnoi M, Raina N, Singh M, Verma P, Gupta P Oncol Res. 2024; 32(1):19-47.

PMID: 38188681 PMC: 10767243. DOI: 10.32604/or.2023.042228.

References

Sramkoski R, Pretlow 2nd T, Giaconia J, Pretlow T, Schwartz S, Sy M . A new human prostate carcinoma cell line, 22Rv1. In Vitro Cell Dev Biol Anim. 1999; 35(7):403-9. DOI: 10.1007/s11626-999-0115-4. View

Mitchell S, Zhu W, Young C . Resveratrol inhibits the expression and function of the androgen receptor in LNCaP prostate cancer cells. Cancer Res. 1999; 59(23):5892-5. View

Hanahan D, Weinberg R . The hallmarks of cancer. Cell. 2000; 100(1):57-70. DOI: 10.1016/s0092-8674(00)81683-9. View

El Etreby M, Liang Y, Lewis R . Induction of apoptosis by mifepristone and tamoxifen in human LNCaP prostate cancer cells in culture. Prostate. 2000; 43(1):31-42. DOI: 10.1002/(sici)1097-0045(20000401)43:1<31::aid-pros5>3.0.co;2-#. View

Scalbert A, Williamson G . Dietary intake and bioavailability of polyphenols. J Nutr. 2000; 130(8S Suppl):2073S-85S. DOI: 10.1093/jn/130.8.2073S. View

Abate-Shen C, Shen M . Molecular genetics of prostate cancer. Genes Dev. 2000; 14(19):2410-34. DOI: 10.1101/gad.819500. View

Kampa M, Hatzoglou A, Notas G, Damianaki A, Bakogeorgou E, Gemetzi C . Wine antioxidant polyphenols inhibit the proliferation of human prostate cancer cell lines. Nutr Cancer. 2001; 37(2):223-33. DOI: 10.1207/S15327914NC372_16. View

Xing N, Chen Y, Mitchell S, Young C . Quercetin inhibits the expression and function of the androgen receptor in LNCaP prostate cancer cells. Carcinogenesis. 2001; 22(3):409-14. DOI: 10.1093/carcin/22.3.409. View

Young I, Woodside J . Antioxidants in health and disease. J Clin Pathol. 2001; 54(3):176-86. PMC: 1731363. DOI: 10.1136/jcp.54.3.176. View

10.

Salganik R . The benefits and hazards of antioxidants: controlling apoptosis and other protective mechanisms in cancer patients and the human population. J Am Coll Nutr. 2001; 20(5 Suppl):464S-472S; discussion 473S-475S. DOI: 10.1080/07315724.2001.10719185. View

11.

GROSSMANN M, Huang H, Tindall D . Androgen receptor signaling in androgen-refractory prostate cancer. J Natl Cancer Inst. 2001; 93(22):1687-97. DOI: 10.1093/jnci/93.22.1687. View

12.

Chen M, Shah V, Patnaik R, Adams W, Hussain A, Conner D . Bioavailability and bioequivalence: an FDA regulatory overview. Pharm Res. 2002; 18(12):1645-50. DOI: 10.1023/a:1013319408893. View

13.

Fritz W, Wang J, Eltoum I, Lamartiniere C . Dietary genistein down-regulates androgen and estrogen receptor expression in the rat prostate. Mol Cell Endocrinol. 2002; 186(1):89-99. DOI: 10.1016/s0303-7207(01)00663-3. View

14.

Kuwajerwala N, Cifuentes E, Gautam S, Menon M, Barrack E, Reddy G . Resveratrol induces prostate cancer cell entry into s phase and inhibits DNA synthesis. Cancer Res. 2002; 62(9):2488-92. View

15.

Kucway R, Vicini F, Huang R, Stromberg J, Gonzalez J, Martinez A . Prostate volume reduction with androgen deprivation therapy before interstitial brachytherapy. J Urol. 2002; 167(6):2443-7. View

16.

Suzuki K, Koike H, Matsui H, Ono Y, Hasumi M, Nakazato H . Genistein, a soy isoflavone, induces glutathione peroxidase in the human prostate cancer cell lines LNCaP and PC-3. Int J Cancer. 2002; 99(6):846-52. DOI: 10.1002/ijc.10428. View

17.

Li Y, Sarkar F . Down-regulation of invasion and angiogenesis-related genes identified by cDNA microarray analysis of PC3 prostate cancer cells treated with genistein. Cancer Lett. 2002; 186(2):157-64. DOI: 10.1016/s0304-3835(02)00349-x. View

18.

Zhou J, Yu L, Zhong Y, Nassr R, Franke A, Gaston S . Inhibition of orthotopic growth and metastasis of androgen-sensitive human prostate tumors in mice by bioactive soybean components. Prostate. 2002; 53(2):143-53. PMC: 2777759. DOI: 10.1002/pros.10141. View

19.

Holt R, Lazarus S, Sullards M, Zhu Q, Schramm D, Hammerstone J . Procyanidin dimer B2 [epicatechin-(4beta-8)-epicatechin] in human plasma after the consumption of a flavanol-rich cocoa. Am J Clin Nutr. 2002; 76(4):798-804. DOI: 10.1093/ajcn/76.4.798. View

20.

Han M, Partin A, Zahurak M, Piantadosi S, Epstein J, Walsh P . Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer. J Urol. 2003; 169(2):517-23. DOI: 10.1097/01.ju.0000045749.90353.c7. View